4D Molecular Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
4D Molecular Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2024.
  • 4D Molecular Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -508K %, a 93113% decline year-over-year.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2024 was -508K %, a 93113% decline from 2023.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2023 was -545 %, a 84.5% increase from 2022.
  • 4D Molecular Therapeutics, Inc. annual Operating Margin for 2022 was -3.52K %, a 789% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -508K -507K -93113% Oct 1, 2024 Dec 31, 2024
Q3 2024 -935K -935K -195915% Jul 1, 2024 Sep 30, 2024
Q2 2024 -649 +4.49K +87.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -591 +4.56K +88.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -545 +2.97K +84.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -477 +4.9K +91.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -5.14K -1.54K -42.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -5.15K -4.68K -992% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.52K -3.12K -789% Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.38K -4.98K -1262% Jul 1, 2022 Sep 30, 2022
Q2 2022 -3.6K -3.37K -1490% Apr 1, 2022 Jun 30, 2022
Q1 2022 -472 +22.6 +4.56% Jan 1, 2022 Mar 31, 2022
Q4 2021 -395 +20.8 +5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -395 Jul 1, 2021 Sep 30, 2021
Q2 2021 -226 Apr 1, 2021 Jun 30, 2021
Q1 2021 -494 Jan 1, 2021 Mar 31, 2021
Q4 2020 -416 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.